Suppr超能文献

吉非替尼治疗肺腺癌垂体转移所致中枢性尿崩症失败。

Gefitinib Treatment Was Unsuccessful for Central Diabetes Insipidus Due to Pituitary Metastasis of Lung Adenocarcinoma.

机构信息

Department of Respiratory Medicine, Japanese Red Cross Society Suwa Hospital, Japan.

Department of Radiation Oncology, Japanese Red Cross Society Suwa Hospital, Japan.

出版信息

Intern Med. 2021 Apr 1;60(7):1073-1076. doi: 10.2169/internalmedicine.5643-20. Epub 2020 Nov 9.

Abstract

We herein report a rare case of advanced lung adenocarcinoma with central diabetes insipidus due to pituitary metastasis. Although treatment with gefitinib was dramatically effective, the symptoms of diabetes insipidus did not improve. Radiotherapy for pituitary metastasis was effective to control diabetes insipidus; however, we could not cease the administration of 1-deamino-8-D-arginine vasopressin (DDAVP). It is important for physicians to positively consider radiotherapy for pituitary metastases even if favorable tumor control is achieved with chemotherapy when diabetes insipidus becomes clinically overt. Furthermore, continuous DDAVP administration may be needed to treat central diabetes insipidus.

摘要

我们在此报告一例罕见的晚期肺腺癌病例,该病例由于垂体转移导致中枢性尿崩症。尽管吉非替尼治疗效果显著,但尿崩症症状并未改善。垂体转移的放射治疗对控制尿崩症有效;然而,我们不能停止使用 1-脒基-8-D-精氨酸血管加压素(DDAVP)的治疗。当临床出现明显的尿崩症时,即使化疗能够很好地控制肿瘤,医生也应积极考虑对垂体转移灶进行放疗,这一点很重要。此外,可能需要持续给予 DDAVP 来治疗中枢性尿崩症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba14/8079922/cea9d2880bf4/1349-7235-60-1073-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验